FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095877110> ?p ?o ?g. }

• W3095877110 endingPage "188" @default.
• W3095877110 startingPage "188" @default.
• W3095877110 abstract "Transforming growth factor-β1 (TGF-β1) acts as a tumor promoter in advanced prostate cancer (PCa). We speculated that microRNAs (miRNAs) that are inhibited by TGF-β1 might exert anti-tumor effects. To assess this, we identified several miRNAs downregulated by TGF-β1 in PCa cell lines and selected miR-3691-3p for detailed analysis as a candidate anti-oncogene miRNA. miR-3691-3p was expressed at significantly lower levels in human PCa tissue compared with paired benign prostatic hyperplasia tissue, and its expression level correlated inversely with aggressive clinical pathological features. Overexpression of miR-3691-3p in PCa cell lines inhibited proliferation, migration, and invasion, and promoted apoptosis. The miR-3691-3p target genes E2F transcription factor 3 (E2F3) and PR domain containing 1, with ZNF domain (PRDM1) were upregulated in miR-3691-3p-overexpressing PCa cells, and silencing of E2F3 or PRDM1 suppressed PCa cell proliferation, migration, and invasion. Treatment of mice bearing PCa xenografts with a miR-3691-3p agomir inhibited tumor growth and promoted tumor cell apoptosis. Consistent with the negative regulation of E2F3 and PRDM1 by miR-3691-3p, both proteins were overexpressed in clinical PCa specimens compared with noncancerous prostate tissue. Our results indicate that TGF-β1-regulated miR-3691-3p acts as an anti-oncogene in PCa by downregulating E2F3 and PRDM1. These results provide novel insights into the mechanisms by which TGF-β1 contributes to the progression of PCa." @default.
• W3095877110 created "2020-11-09" @default.
• W3095877110 creator A5002952341 @default.
• W3095877110 creator A5004599279 @default.
• W3095877110 creator A5010747851 @default.
• W3095877110 creator A5013116262 @default.
• W3095877110 creator A5018136969 @default.
• W3095877110 creator A5019994767 @default.
• W3095877110 creator A5021634528 @default.
• W3095877110 creator A5035085609 @default.
• W3095877110 creator A5037575379 @default.
• W3095877110 creator A5071215161 @default.
• W3095877110 creator A5074335468 @default.
• W3095877110 creator A5075086137 @default.
• W3095877110 date "2021-01-01" @default.
• W3095877110 modified "2023-10-05" @default.
• W3095877110 title "TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression" @default.
• W3095877110 cites W112717901 @default.
• W3095877110 cites W1839137025 @default.
• W3095877110 cites W1963499832 @default.
• W3095877110 cites W1963871654 @default.
• W3095877110 cites W1967801503 @default.
• W3095877110 cites W1969033963 @default.
• W3095877110 cites W1984252723 @default.
• W3095877110 cites W1987265108 @default.
• W3095877110 cites W1995885266 @default.
• W3095877110 cites W1996752433 @default.
• W3095877110 cites W1999792045 @default.
• W3095877110 cites W2007003847 @default.
• W3095877110 cites W2009214757 @default.
• W3095877110 cites W2016810184 @default.
• W3095877110 cites W2018077352 @default.
• W3095877110 cites W2023153709 @default.
• W3095877110 cites W2027011635 @default.
• W3095877110 cites W2033522935 @default.
• W3095877110 cites W2034608727 @default.
• W3095877110 cites W2040824502 @default.
• W3095877110 cites W2050125144 @default.
• W3095877110 cites W2058378456 @default.
• W3095877110 cites W2086180502 @default.
• W3095877110 cites W2095236629 @default.
• W3095877110 cites W2097477872 @default.
• W3095877110 cites W2102500432 @default.
• W3095877110 cites W2110935705 @default.
• W3095877110 cites W2126350805 @default.
• W3095877110 cites W2131211068 @default.
• W3095877110 cites W2136242244 @default.
• W3095877110 cites W2136280424 @default.
• W3095877110 cites W2139992910 @default.
• W3095877110 cites W2145191832 @default.
• W3095877110 cites W2154409398 @default.
• W3095877110 cites W2160737079 @default.
• W3095877110 cites W2160968516 @default.
• W3095877110 cites W2171352366 @default.
• W3095877110 cites W2280923709 @default.
• W3095877110 cites W2301036151 @default.
• W3095877110 cites W2595805911 @default.
• W3095877110 cites W2606709102 @default.
• W3095877110 cites W2792899993 @default.
• W3095877110 cites W2803662539 @default.
• W3095877110 cites W2964635080 @default.
• W3095877110 cites W4211024301 @default.
• W3095877110 doi "https://doi.org/10.4103/aja.aja_60_20" @default.
• W3095877110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7991816" @default.
• W3095877110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33159025" @default.
• W3095877110 hasPublicationYear "2021" @default.
• W3095877110 type Work @default.
• W3095877110 sameAs 3095877110 @default.
• W3095877110 citedByCount "7" @default.
• W3095877110 countsByYear W30958771102021 @default.
• W3095877110 countsByYear W30958771102022 @default.
• W3095877110 countsByYear W30958771102023 @default.
• W3095877110 crossrefType "journal-article" @default.
• W3095877110 hasAuthorship W3095877110A5002952341 @default.
• W3095877110 hasAuthorship W3095877110A5004599279 @default.
• W3095877110 hasAuthorship W3095877110A5010747851 @default.
• W3095877110 hasAuthorship W3095877110A5013116262 @default.
• W3095877110 hasAuthorship W3095877110A5018136969 @default.
• W3095877110 hasAuthorship W3095877110A5019994767 @default.
• W3095877110 hasAuthorship W3095877110A5021634528 @default.
• W3095877110 hasAuthorship W3095877110A5035085609 @default.
• W3095877110 hasAuthorship W3095877110A5037575379 @default.
• W3095877110 hasAuthorship W3095877110A5071215161 @default.
• W3095877110 hasAuthorship W3095877110A5074335468 @default.
• W3095877110 hasAuthorship W3095877110A5075086137 @default.
• W3095877110 hasBestOaLocation W30958771101 @default.
• W3095877110 hasConcept C104317684 @default.
• W3095877110 hasConcept C119056186 @default.
• W3095877110 hasConcept C121608353 @default.
• W3095877110 hasConcept C145059251 @default.
• W3095877110 hasConcept C153911025 @default.
• W3095877110 hasConcept C2780192828 @default.
• W3095877110 hasConcept C2781018059 @default.
• W3095877110 hasConcept C29537977 @default.
• W3095877110 hasConcept C502942594 @default.
• W3095877110 hasConcept C54355233 @default.
• W3095877110 hasConcept C555283112 @default.
• W3095877110 hasConcept C62112901 @default.

• next